Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1
Keywords:
Asparaginase; acute lymphoblastic leukemia; allergy;
anaphylaxis; brain disease; drug safety; febrile neutropenia; hyperbilirubinemia; hypertriglyceridemial; liver failure; major clinical study; sepsis